StockNews.com assumed coverage on shares of Brooklyn ImmunoTherapeutics (NYSE:BTX – Free Report) in a report issued on Wednesday morning. The brokerage issued a hold rating on the stock.
Brooklyn ImmunoTherapeutics Stock Performance
Brooklyn ImmunoTherapeutics stock opened at $0.29 on Wednesday. The firm has a 50 day moving average price of $0.60 and a two-hundred day moving average price of $1.24. Brooklyn ImmunoTherapeutics has a 52-week low of $0.17 and a 52-week high of $10.10. The firm has a market cap of $17.29 million, a price-to-earnings ratio of -0.13 and a beta of 4.61.
Brooklyn ImmunoTherapeutics Company Profile
Further Reading
- Five stocks we like better than Brooklyn ImmunoTherapeutics
- How to Invest in Tech Stocks and Top Tech Stocks to Consider
- Work and Play: Investing in the Rise of Bleisure Travel
- Differences Between Momentum Investing and Long Term Investing
- Top Dividend Stocks to Buy Now as Bond Yields Could Lower
- Short Selling: How to Short a Stock
- SAP: AI Tailwinds Accelerating Enterprise Cloud Business
Receive News & Ratings for Brooklyn ImmunoTherapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Brooklyn ImmunoTherapeutics and related companies with MarketBeat.com's FREE daily email newsletter.
